Tra2β, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA

Shinichi Kondo, Noriaki Yamamoto, Tomohiko Murakami, Masayo Okumura, Akira Maeda, Kazunori Imaizumi

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Some of mutations in the tau gene, which were found in frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), affect alternative splicing of its exon 10 which encodes one of four microtubule-binding motifs. To examine the molecular mechanisms responsible for aberrant splicing of the tau gene containing mutations linked to FTDP-17, we performed Exon trapping and binding assay using tau exon 10 pre-mRNA and nuclear extracts of neuro-blastoma cell lines and in vitro splicing using dsx-substrate. We determined that 5′ site of tau exon 10 (nucleotides 12-45) possesses exonic splicing enhancer (ESE) activities in vitro splicing and the FTDP-17-linked mutations affect the ESE activities and alter the splicing patterns of tau exon 10. Tra2β directly and ASF/SF2 indirectly associated with the ESE of wild tau exon 10. The binding amounts of these SR proteins to tau exon 10 bearing N279K mutation increased and they enhanced splicing the mutant tau exon 10. SRp30c also enhanced the splicing of tau exon 10. These results suggest that mutations in tau exon 10 that are linked to FTDP-17 affect the ESE activities by altering the binding of some SR proteins to its pre-mRNA.

Original languageEnglish
Pages (from-to)121-130
Number of pages10
JournalGenes to Cells
Volume9
Issue number2
DOIs
Publication statusPublished - 01-02-2004

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Genetics
  • Cell Biology

Cite this